Chagas disease and transfusion medicine: a perspective from non-endemic countries.
暂无分享,去创建一个
G. Aprili | F. Gobbi | Z. Bisoffi | S. Pupella | G. Gandini | A. Angheben | D. Buonfrate | Lucía Boix
[1] P. Buekens,et al. Congenital Chagas disease: an update , 2015, Memorias do Instituto Oswaldo Cruz.
[2] P. Chiodini,et al. Health Policies to Control Chagas Disease Transmission in European Countries , 2014, PLoS neglected tropical diseases.
[3] J. M. Rubio,et al. The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets , 2014, Transfusion.
[4] Fernando Salvador,et al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. , 2014, The New England journal of medicine.
[5] M. Ndao,et al. Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer “no” to risk questions , 2014, Transfusion.
[6] Maria Elena Bottazzi,et al. An Unfolding Tragedy of Chagas Disease in North America , 2013, PLoS neglected tropical diseases.
[7] G. Girelli,et al. Surveillance of Chagas disease among at-risk blood donors in Italy: preliminary results from Umberto I Polyclinic in Rome. , 2013, Blood transfusion = Trasfusione del sangue.
[8] M. Ndao,et al. Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services , 2013, Transfusion.
[9] D. Kessler,et al. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center , 2013, Transfusion.
[10] R. Goodrich,et al. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion‐associated graft‐versus‐host disease? , 2013, Transfusion.
[11] P. Chiodini,et al. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem , 2012, Transfusion.
[12] S. Montgomery,et al. The United States Trypanosoma cruzi Infection Study: evidence for vector‐borne transmission of the parasite that causes Chagas disease among United States blood donors , 2012, Transfusion.
[13] S. Weisenberg,et al. Seroprevalence of Chagas Infection in the Donor Population , 2012, PLoS neglected tropical diseases.
[14] M. Shikanai-Yasuda,et al. Oral transmission of Chagas disease. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] R. Goodrich,et al. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood , 2012, Transfusion.
[16] G. Russomando,et al. Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women , 2011, PLoS neglected tropical diseases.
[17] P. Chiodini,et al. Chagas disease in European countries: the challenge of a surveillance system. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[18] E. Bonifacio,et al. Chagas disease in Italy: breaking an epidemiological silence. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[19] M. Segovia,et al. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. , 2011, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[20] R. López-Vélez,et al. Chagas disease in Latin American migrants: a Spanish challenge. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[21] D. Boykin,et al. In vitro trypanocidal activity of DB745B and other novel arylimidamides against Trypanosoma cruzi. , 2011, The Journal of antimicrobial chemotherapy.
[22] M. Ison,et al. Screening and Treatment of Chagas Disease in Organ Transplant Recipients in the United States: Recommendations from the Chagas in Transplant Working Group , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] A. Hasslocher-Moreno,et al. ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis , 2010, BMC infectious diseases.
[24] B. Custer,et al. Cost‐effectiveness of screening the US blood supply for Trypanosoma cruzi , 2010, Transfusion.
[25] S. Wendel. Transfusion transmitted Chagas disease: is it really under control? , 2010, Acta tropica.
[26] Z. Yadón,et al. Chagas disease: a Latin American health problem becoming a world health problem. , 2010, Acta tropica.
[27] J. Gascón,et al. Chagas disease and stroke , 2010, The Lancet Neurology.
[28] J. Sztajzel,et al. Prevalence, Clinical Staging and Risk for Blood-Borne Transmission of Chagas Disease among Latin American Migrants in Geneva, Switzerland , 2010, PLoS neglected tropical diseases.
[29] R. López-Vélez,et al. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. , 2009, The Journal of antimicrobial chemotherapy.
[30] S. Yusuf,et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. , 2009, Memorias do Instituto Oswaldo Cruz.
[31] Anita Sands,et al. WHO comparative evaluation of serologic assays for Chagas disease , 2009, Transfusion.
[32] E. Castro. Chagas’ disease: lessons from routine donation testing , 2009, Transfusion medicine.
[33] D. Grana,et al. Chagas cardiomyopathy: Europe is not spared! , 2008, European heart journal.
[34] S. Montgomery,et al. Chagas disease and the US blood supply , 2008, Current opinion in infectious diseases.
[35] S. Sauleda,et al. Seroprevalence of Trypanosoma cruzi infection in at‐risk blood donors in Catalonia (Spain) , 2008, Transfusion.
[36] Maria Elena Bottazzi,et al. The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination , 2008, PLoS neglected tropical diseases.
[37] P. Leiva. Faculty Opinions recommendation of Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. , 2008 .
[38] J. Chiavetta,et al. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing , 2008, Transfusion.
[39] T. Garate,et al. Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] Robert H Gilman,et al. Evaluation and treatment of chagas disease in the United States: a systematic review. , 2007, JAMA.
[41] G. Schmuñis. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. , 2007, Memorias do Instituto Oswaldo Cruz.
[42] R. Goodrich,et al. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. , 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[43] S. Wagner,et al. Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium. , 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[44] E. Peresi,et al. Definition of a diagnostic routine in individuals with inconclusive serology for Chagas disease. , 2007, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[45] L. Glasser,et al. Transfusion‐acquired Trypanosoma cruzi infection , 2007, Transfusion.
[46] M. Fresno,et al. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy‐coat platelets , 2007, Transfusion.
[47] O. Garraud,et al. Measures to prevent transfusion-associated protozoal infections in non-endemic countries. , 2007, Travel medicine and infectious disease.
[48] M. Fresno,et al. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma , 2006, Vox sanguinis.
[49] L. Sawyer,et al. Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function , 2006, Transfusion.
[50] S. Trevethan,et al. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. , 2005, Memorias do Instituto Oswaldo Cruz.
[51] J. R. Cruz,et al. Safety of the Blood Supply in Latin America , 2005, Clinical Microbiology Reviews.
[52] E. Silveira-Lacerda,et al. Chagas’ disease: application of TESA‐blot in inconclusive sera from a Brazilian blood bank , 2004, Vox sanguinis.
[53] A. Farrugia. The mantra of blood safety: time for a new tune? , 2004, Vox sanguinis.
[54] W. V. Van Voorhis,et al. Trypanosoma cruzi Inactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UV , 2003, Antimicrobial Agents and Chemotherapy.
[55] Sergio L Vargas,et al. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up , 2003, Annals of tropical medicine and parasitology.
[56] C. Beard,et al. Control of Chagas Disease. Second Report of the WHO Expert Committee. WHO Technical Report Series, No. 905. Geneva: World Health Organization, 2002. vi + 109pp. Price Sw.fr. 23/US$20.70 (in developing countries Sw.fr.16.10). ISBN 92-4-120905.4 , 2002 .
[57] E. Chiari,et al. Aminoquinolone WR6026 as a feasible substitute for gentian violet in Chagas' disease prophylaxis in preserved blood for transfusional purposes. , 2002, Revista da Sociedade Brasileira de Medicina Tropical.
[58] J. Dias,et al. The impact of Chagas disease control in Latin America: a review. , 2002, Memorias do Instituto Oswaldo Cruz.
[59] M. Guariento,et al. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. , 2002, Diagnostic microbiology and infectious disease.
[60] A Prata,et al. Clinical and epidemiological aspects of Chagas disease. , 2001, The Lancet. Infectious diseases.
[61] L. Corash,et al. Inactivation of infectious pathogens in labile blood components: meeting the challenge. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
[62] D. Leiby,et al. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. , 1999, The New England journal of medicine.
[63] S. Wendel. Transfusion-transmitted Chagas' disease. , 1998, Current opinion in hematology.
[64] J. Coura,et al. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease , 1996, Journal of clinical microbiology.
[65] L V Kirchhoff,et al. American Trypanosomiasis (Chagas Disease) , 2018, Red Book (2018).
[66] M. Blajchman,et al. Prevention of transfusion‐associated Chagas' disease: efficacy of white cell‐reduction filters in removing Trypanosoma cruzi from infected blood , 1995, Transfusion.
[67] E. Lages-Silva,et al. Prevention of transfusion‐associated Chagas' disease by sterilization of Trypanosoma cruzi‐infected blood with gentian violet, ascorbic acid, and light , 1995, Transfusion.
[68] A. Pan,et al. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity , 1995, Transfusion.
[69] S. Wendel. Chagas Disease: An Old Entity in New Places , 1993, The International journal of artificial organs.
[70] S. Wendel,et al. Chagas' Disease and Blood Transfusion: A New World Problem? , 1993, Vox sanguinis.
[71] L. Kirchhoff,et al. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi , 1993, Transfusion.
[72] G. Schmuñis. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries , 1991, Transfusion.
[73] H. Tanowitz,et al. Transfusion-associated acute Chagas disease acquired in the United States. , 1989, Annals of internal medicine.
[74] R. Docampo,et al. Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate. , 1988, Molecular and biochemical parasitology.
[75] H. Hendrickson. Prevention of what? , 1983, Journal of the American Optometric Association.
[76] J. Pruneda,et al. [Chagas' disease and blood transfusion]. , 1972, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.
[77] A. Trejos,et al. [Strout's concentration method in the diagnosis of acute Chagas disease]. , 1966, Boletin chileno de parasitologia.
[78] 김성,et al. Transmission , 1922, Sexistence.
[79] M. Keenan,et al. A new era for chagas disease drug discovery? , 2015, Progress in medicinal chemistry.
[80] J. Rojo Medina. [Blood Safety in the XXI century. Transfusion transmitted infectious diseases. International and Mexican view]. , 2014, Gaceta medica de Mexico.
[81] O. Ritter,et al. Epidemiology of Chagas disease in Europe: many calculations, little knowledge , 2013, Clinical Research in Cardiology.
[82] Margaret Chan,et al. Sustaining the drive to overcome the global impact of neglected tropical diseases : second WHO report on neglected tropical diseases , 2013 .
[83] A. Assal,et al. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries]. , 2011, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
[84] T. Garate,et al. [Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain]. , 2010, Enfermedades infecciosas y microbiologia clinica.
[85] R. López-Vélez,et al. Chagas disease in a recipient of cord blood transplantation , 2007, Bone Marrow Transplantation.
[86] P. Cimo,et al. Transfusion-associated Chagas' disease in Texas: report of a case. , 1993, Texas medicine.
[87] V. Amato Neto,et al. [First tests on the accidental transmission of Chagas disease to man by blood transfusion]. , 1952, Revista paulista de medicina.